| Property |
Value |
| Gene Symbol |
PEX12 |
| Full Name |
Peroxisome Biogenesis Factor 12 |
| Chromosomal Location |
17q12 |
| NCBI Gene ID |
5253 |
| OMIM ID |
601758 |
| Ensembl ID |
ENSG00000109667 |
| UniProt ID |
O00634 |
| Protein Length |
359 amino acids |
| Molecular Weight |
~40 kDa |
| Associated Diseases |
Zellweger Spectrum Disorders, Neonatal Adrenoleukodystrophy |
PEX12 (Peroxisome Biogenesis Factor 12) is a gene located on chromosome 17q12 that encodes a peroxin essential for peroxisome biogenesis and function. PEX12 is a RING finger domain-containing E3 ubiquitin ligase that forms part of the peroxisomal import machinery, specifically the peroxisomal targeting signal (PTS) receptor docking complex. PEX12 mutations cause peroxisome biogenesis disorders (PBDs), including Zellweger syndrome, neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease, all characterized by severe neurological dysfunction and early-onset neurodegeneration[@steinberg2004].
Peroxisomes are essential organelles that play critical roles in fatty acid oxidation, plasmalogen synthesis, reactive oxygen species metabolism, and ether phospholipid biosynthesis. The connection between peroxisomal dysfunction and neurodegenerative diseases has become increasingly apparent, with peroxisomal defects implicated in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis[@herms2014].
¶ Structure and Function
¶ Protein Domain Architecture
PEX12 contains distinctive structural features:
- N-terminal region: Cytoplasmic domain for PEX5 interaction
- RING finger domain: C3HC4-type zinc finger for E3 ligase activity
- C-terminal region: Peroxisomal membrane anchor
- PEX5-binding site: Direct interaction with peroxin
The RING finger domain of PEX12[@eckert2010]:
- E3 ubiquitin ligase activity: Catalyzes ubiquitination of PEX5
- Ubiquitin chain formation: Generates K48-linked chains for proteasomal degradation
- Monoubiquitination: PEX5 monoubiquitination for recycling
- Quality control: Targets misfolded proteins for degradation
PEX12 is part of the peroxisomal import machinery:
| Component |
Function |
| PEX5 |
PTS1 receptor, binds cargo in cytosol |
| PEX12 |
Docking component, E3 ligase |
| PEX10 |
RING finger protein, E3 ligase |
| PEX2 |
Membrane component |
| PEX16 |
Peroxisomal membrane protein |
PEX12 is essential for importing peroxisomal matrix proteins[@nagata2010]:
- Cargo recognition: PEX5 binds PTS1 cargo in cytosol
- Docking complex: PEX5-PEX12-PEX10-PEX2 complex formation
- Translocation: Cargo passes through peroxisomal membrane
- PEX5 ubiquitination: PEX12 ubiquitinates PEX5
- PEX5 recycling: Ubiquitinated PEX5 extracted and recycled
PEX12 orchestrates peroxisome formation:
- De novo formation: Required for new peroxisome assembly
- Growth and division: Controls peroxisome proliferation
- Quality control: Maintains functional peroxisome population
PEX12 functions in peroxisomal quality control[@schrader2019]:
- Misfolded protein degradation: Targets abnormal proteins
- Damaged organelle removal: Controls peroxisome turnover
- Import competency: Ensures proper import machinery function
PEX12 mutations cause severe peroxisome biogenesis disorders[@waterham2016]:
- Severe neurological dysfunction: Profound intellectual disability
- Hypotonia: Reduced muscle tone
- Seizures: Epileptic activity
- Visual impairment: Retinal dystrophy, optic atrophy
- Hearing loss: Sensorineural deafness
- Craniofacial dysmorphism: Characteristic facial features
- Hepatic dysfunction: Liver enlargement, cholestasis
- Failure to thrive: Growth retardation
- Zellweger syndrome: Most severe, neonatal onset
- Neonatal adrenoleukodystrophy: Intermediate severity
- Infantile Refsum disease: Milder, later onset
Peroxisomal dysfunction leads to neurodegeneration through multiple pathways[@brazile2019]:
- Toxicity: Very long-chain fatty acids damage myelin
- Inflammation: Triggers neuroinflammatory responses
- Membrane disruption: Alters neuronal membrane composition
- Myelin defects: Reduced plasmalogens impair myelination
- Synaptic dysfunction: Altered lipid rafts
- Neuronal signaling: Impaired signal transduction
- ROS accumulation: Impaired antioxidant defenses
- Lipid peroxidation: Damages neuronal membranes
- DNA damage: Contributes to neuronal death
PEX12 and peroxisomes are implicated in Alzheimer's disease[@vanvliet2015]:
- Reduced peroxisomes: Decreased peroxisome numbers in AD brain
- PEX12 alterations: Changed expression in AD neurons
- VLCFA accumulation: Elevated in AD brain
- Plasmalogen loss: Reduced in AD
- Amyloid interaction: Peroxisomes respond to Aβ
- Tau pathology: Peroxisomal dysfunction in tauopathies
- Metabolic defects: Altered lipid metabolism
In Parkinson's disease:
- Peroxisomal defects: Observed in PD substantia nigra
- VLCFA metabolism: Altered in PD brain
- Oxidative stress: Peroxisomal ROS handling impaired
PEX12 in ALS:
- Motor neuron vulnerability: High peroxisome content
- Energy demands: Fatty acid oxidation needed
- Oxidative stress: Enhanced ROS in ALS
PTS1 cargo + PEX5 → Docking complex (PEX12/PEX10/PEX2)
↓
Translocation into peroxisome
↓
PEX12-mediated ubiquitination
↓
PEX5 recycling
- PPARα activation: Regulates peroxisome proliferation
- Fatty acid sensing: Links metabolism to peroxisome function
- PEX11: Peroxisome division regulator
PEX12 regulates:
- β-oxidation: Very long-chain fatty acids
- ether phospholipid synthesis: Plasmalogens
- bile acid synthesis: Cholesterol metabolism
- Ubiquitous: All tissues require peroxisomes
- High expression: Liver, kidney, brain
- Cellular localization: Peroxisomal membrane
In the central nervous system:
| Cell Type |
Expression |
Function |
| Neurons |
High |
High lipid metabolism |
| Astrocytes |
Moderate |
Lipid processing |
| Oligodendrocytes |
High |
Myelin production |
| Microglia |
Moderate |
ROS metabolism |
- Peroxisomal membrane: Integral membrane protein
- Cytoplasmic face: N-terminal domain accessible
- Lumenal domain: C-terminal region
PEX12 and peroxisomes represent therapeutic targets[@ibrahim2020]:
| Approach |
Strategy |
Status |
| Gene therapy |
Restore PEX12 function |
Research |
| Small molecules |
Enhance peroxisome function |
Discovery |
| VLCFA reduction |
Lower toxic metabolites |
Clinical |
| Plasmalogen supplementation |
Restore membrane lipids |
Preclinical |
- CNS delivery across blood-brain barrier
- Achieving peroxisome restoration
- Balancing metabolic functions
- Long-term safety
- Mouse knockout: Embryonic lethal
- Conditional knockout: Neuron-specific shows neurodegeneration
- Phenotypes: Peroxisome deficiency, neurological dysfunction
- PEX12-deficient mice: Recapitulate ZSD features
- Peroxisome deficiency: Shows neuronal loss
PEX12 interacts with:
- PEX5: Receptor docking
- PEX10: RING finger complex
- PEX2: Import machinery
- PEX16: Membrane assembly
- Ubiquitin-proteasome system: E3 ligase function
- Lipid metabolism enzymes: Functional partnerships
- Cytoskeletal proteins: Cellular organization
- Okumoto K, et al. PEX12 functions as a peroxisomal ubiquitin ligase. J Biol Chem. 1998
- Steinberg SJ, et al. PEX12 mutations in peroxisome biogenesis disorders. Hum Mol Genet. 2004
- Waterham HR, et al. Peroxisome biogenesis disorders. Am J Med Genet C Semin Med Genet. 2016
- Eckert D, et al. PEX12 structure and function in peroxisome assembly. Traffic. 2010
- Brazile W, et al. Peroxisomes in neuronal function and dysfunction. J Neurochem. 2019
- Herms J, et al. Peroxisomal dysfunction in neurodegenerative disease. Nat Rev Neurosci. 2014
- Jiang Y, et al. PEX12 and peroxisomal import machinery. Mol Cell Biol. 2016
- Itoh Y, et al. PEX12 and PEX5 ubiquitination. J Cell Sci. 2012
- Nagata S, et al. Peroxisomal import receptors and disorders. J Inherit Metab Dis. 2010
- Saori K, et al. Peroxisomes in brain development and disease. Biochim Biophys Acta. 2016
- Terrake A, et al. PEX12-containing peroxisomal import complex. J Cell Biol. 2019
- Agarrabera L, et al. Peroxisomes and fatty acid oxidation in neurons. Cell Rep. 2020
- Moir LM, et al. Peroxisome biogenesis disorders: clinical spectrum. Ann Neurol. 2016
- Correa PM, et al. PEX12 deficiency and oxidative stress. Free Radic Biol Med. 2015
- Hu CH, et al. Peroxisomal VLCFA metabolism in neurodegeneration. Mol Neurobiol. 2019
- Van Vliet T, et al. Peroxisomes in Alzheimer's disease pathology. Acta Neuropathol Commun. 2015
- Lismont C, et al. Peroxisomes and ROS metabolism. Antioxid Redox Signal. 2015
- Schrader M, et al. Peroxisome quality control mechanisms. Traffic. 2019
- Kovacs WJ, et al. Peroxisome biogenesis in neural stem cells. Dev Cell. 2019
- Ibrahim SA, et al. Targeting peroxisomes for neurodegenerative disease therapy. Nat Rev Neurol. 2020